Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Estrella Immunopharma, Inc. (ESLA) vs TScan Therapeutics, Inc. (TCRX)

Estrella Immunopharma, Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. TScan Therapeutics, Inc. is the larger, with a market value of $23.7M against $20.5M — 1.2× the size. Estrella Immunopharma, Inc. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 12 metrics below, Estrella Immunopharma, Inc. leads on 9 and TScan Therapeutics, Inc. on 3.

Valuation

Metric ESLA TCRX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 6.21 11.47
P/B n/m 0.64 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.20 0.74
EV/Sales n/m (3.26) 10.73
Earnings yield (50.81%) (267.65%) (28.84%)
Free cash flow yield (45.47%) (268.00%) (23.03%)

Profitability

Metric ESLA TCRX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (1,695.15%) 0.00%
Net margin 0.00% (1,655.35%) 0.00%
Free cash flow margin 0.00% (1,665.18%) 0.00%
Return on equity 148.05% (95.80%) (57.72%)
Return on assets (416.74%) (50.09%) (49.22%)
Return on invested capital 0.00% (4,588.23%) 0.00%

Growth

Metric ESLA TCRX Biotechnology median
Revenue growth (TTM) — 2.15% 5.64%
EPS growth (last fiscal year) (188.78%) 12.28% —
Revenue growth, 5-year CAGR — 56.92% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ESLA TCRX Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 0.20 3.37 4.73
Net debt to EBITDA 0.11 0.90 0.96

Dividend

Metric ESLA TCRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ESLA TCRX Biotechnology median
Market cap 20.49m 23.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack